Abstract
We evaluated clinical presentation, cerebrospinal fluid (CSF), and magnetic resonance imaging (MRI) in patients with late-onset multiple sclerosis (LOMS). Fifty-two patients with definitive multiple sclerosis (MS) diagnosed after the age of 50 years were identified between 1991 and 2002. Data pertaining to clinical characteristics, CSF analysis, and cerebral and spinal MRI were compared with those of 52 young-onset MS (YOMS) patients matched for sex and disease duration. Mean age at the time of diagnosis was 57 years in the LOMS group – the oldest patient was 82 – and 29 years in the YOMS group. Motor symptoms were significantly more often present in the LOMS than in patients with YOMS (90 % vs. 67 %, p = 0.014). Visual symptoms, residual signs of optic neuritis, and dysarthria were less frequent for LOMS. Sensory symptoms, ataxia, oculomotor symptoms, cognitive disorder, or fatigue did not differ between both groups. The majority of LOMS patients (83 %) had a primary progressive disease course, whereas 94 % of the YOMS group had a relapsing-remitting course. MRI showed typical multifocal supratentorial (LOMS vs. YOMS: 96 % vs. 98 %) and infratentorial (44 % vs. 62 %) lesions without significant group differences. Of particular interest, spinal lesions were more common (81 %) in LOMS compared to YOMS (48 %, p = 0.024), and cerebellar lesions were less frequent in the LOMS group (11 % vs. 44 %, p = 0.001). Gadolinium-enhanced lesions were initially present in less LOMS patients (15 %) than in YOMS (63 %, p < 0.001). CSF analysis revealed pleocytosis less frequently in LOMS (34 %) compared to YOMS (67 %, p = 0.006) but oligoclonal banding occurred without in both groups without differences. YOMS patients responded to corticosteroids (93 %) to a significantly greater degree than LOMS patients (73 %; p = 0.004). For individuals who develop LOMS, a primary progressive course is frequent, with motor symptoms as the prominent feature. Vigilance is necessary to recognise MS in this population because of its unusual presentation.
Similar content being viewed by others
References
Cazzullo CL, Ghezzi A, Marforio S, Caputo D (1978) Clinical picture of multiple sclerosis with late onset. Acta Neurol Scand 58:190–196
Confavreux C (2002) Infections and the risk of relapse in multiple sclerosis. Brain 125:933–934
Confavreux C, Aimard G, Devic M (1980) Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 103:281–300
Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126:770–782
Cottrell DA, Kremenchutzky M, Rice GP, Koopman WJ, Hader W, Baskerville J, Ebers GC (1999) The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122(Pt 4):625–639
de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier- Vehier F, Verier A, Pruvo JP, Hache JC, Vermersch P (2002) Devic’s neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 197:57–61
Delalande S, De Seze J, Ferriby D, Stojkovic T, Vermersch P (2002) Late onset multiple sclerosis. Rev Neurol (Paris) 158:1082–1087
Dujmovic I, Mesaros S, Pekmezovic T, Levic Z, Drulovic J (2004) Primary progressive multiple sclerosis: clinical and paraclinical characteristics with application of the new diagnostic criteria. Eur J Neurol 11:439–444
Gomez-Garcia AO, Fernandez-Concepcion O, Milan-Ginjauma E (1997) Clinical-epidemiological characteristics of late onset multiple sclerosis. Rev Neurol 25:1863–1866
Hawkins SA, McDonnell GV (1999) Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 67:148–152
Hooge JP, Redekop WK (1992) Multiple sclerosis with very late onset. Neurology 42:1907–1910
Leibowitz U, Alter M, Halpern L (1964) Clinical studies of multiple sclerosis in Israel. 3. Clinical course and prognosis related to age at onset. Neurology 14:926–932
Levic ZM, Dujmovic I, Pekmezovic T, Jarebinski M, Marinkovic J, Stojsavljevic N, Drulovic J (1999) Prognostic factors for survival in multiple sclerosis. Mult Scler (Houndmills, Basingstoke, England) 5:171–178
Leyhe T, Laske C, Buchkremer G, Wormstall H, Wiendl H (2005) Dementia as a primary symptom in late onset multiple sclerosis. Case series and review of the literature. Nervenarzt 76:748–755
Liguori M, Marrosu MG, Pugliatti M, Giuliani F, De Robertis F, Cocco E, Zimatore GB, Livrea P, Trojano M (2000) Age at onset in multiple sclerosis. Neurol Sci 21:S825–S829
Lyon-Caen O, Izquierdo G, Marteau R, Lhermitte F, Castaigne P, Hauw JJ (1985) Late onset multiple sclerosis. A clinical study of 16 pathologically proven cases. Acta Neurol Scand 72:56–60
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
McDonnell GV, Hawkins SA (1998) An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 50:423–428
Moreau T, Confavreux C (2000) Can the prognosis of multiple sclerosis be predicted? Pathologie-biologie 48:132–138
Moreira MA, Felipe E, Mendes MF, Tilbery CP (2000) Multiple sclerosis: descriptive study of its clinical forms in 302 cases. Arq Neuropsiquiatr 58:460–466
Myhr KM, Riise T, Vedeler C, Nortvedt MW, Gronning R, Midgard R, Nyland HI (2001) Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Sclers (Houndmills, Basingstoke, England) 7:59–65
Noseworthy J, Paty D, Wonnacott T, Feasby T, Ebers G (1983) Multiple sclerosis after age 50. Neurology 33:1537–1544
Noseworthy JH (1993) Clinical trials in multiple sclerosis. Curr Opin Neurol Neurosurg 6:209–215
Polliack ML, Barak Y, Achiron A (2001) Late-onset multiple sclerosis. J Am Geriatr Soc 49:168–171
Poser S, Raun NE, Poser W (1982) Age at onset, initial symptomatology and the course of multiple sclerosis. Acta Neurol Scand 66:355–362
Ramsaransing G, Maurits N, Zwanikken C, De Keyser J (2001) Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult Scler (Houndmills, Basingstoke, England) 7:345–347
Runmarker B, Andersson C, Oden A, Andersen O (1994) Prediction of outcome in multiple sclerosis based on multivariate models. J Neurol 241:597–604
Savettieri G, Messina D, Andreoli V, Bonavita S, Caltagirone C, Cittadella R, Farina D, Fazio MC, Girlanda P, Le Pira F, Liguori M, Lugaresi A, Nocentini U, Reggio A, Salemi G, Tedeschi G, Trojano M, Valentino P, Quattrone A (2004) Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol 251:1208–1214
Tartaglino LM, Friedman DP, Flanders AE, Lublin FD, Knobler RL, Liem M (1995) Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 195:725–732
Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH, Polman CH, Stevenson VL, McDonald WI (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831–835
Thompson AJ, Polman CH, Miller DH, McDonald WI, Brochet B, Filippi MMX, De Sa J (1997) Primary progressive multiple sclerosis. Brain 120(Pt 6):1085–1096
Tremlett H, Devonshire V (2006) Is late-onset multiple sclerosis associated with a worse outcome? Neurology 67:954–959
Trojano M, Avolio C, Manzari C, Calo A, De Robertis F, Serio G, Livrea P (1995) Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry 58:300–306
Visscher BR, Liu KS, Clark VA, Detels R, Malmgren RM, Dudley JP (1984) Onset symptoms as predictors of mortality and disability in multiple sclerosis. Acta Neurol Scand 70:321–328
Weinshenker BG (2000) Progressive forms of MS: classification streamlined or consensus overturned? Lancet 355:162–163
Weinshenker BG, Sibley WA (1992) Natural history and treatment of multiple sclerosis. Curr Opin Neurol Neurosurg 5:203–211
White AD, Swingler RJ, Compston DA (1990) Features of multiple sclerosis in older patients in South Wales. Gerontology 36:159–164
Author information
Authors and Affiliations
Corresponding author
Additional information
Drs. Kis and Rumberg contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kis, B., Rumberg, B. & Berlit, P. Clinical characteristics of patients with late-onset multiple sclerosis. J Neurol 255, 697–702 (2008). https://doi.org/10.1007/s00415-008-0778-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0778-x